Literature DB >> 21854682

Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years.

M Álvarez-Jiménez1, J F Gleeson, L P Henry, S M Harrigan, M G Harris, E Killackey, S Bendall, G P Amminger, A R Yung, H Herrman, H J Jackson, P D McGorry.   

Abstract

BACKGROUND: In recent years there has been increasing interest in functional recovery in the early phase of schizophrenia. Concurrently, new remission criteria have been proposed and several studies have examined their clinical relevance for prediction of functional outcome in first-episode psychosis (FEP). However, the longitudinal interrelationship between full functional recovery (FFR) and symptom remission has not yet been investigated. This study sought to: (1) examine the relationships between FFR and symptom remission in FEP over 7.5 years; (2) test two different models of the interaction between both variables.
METHOD: Altogether, 209 FEP patients treated at a specialized early psychosis service were assessed at baseline, 8 months, 14 months and 7.5 years to determine their remission of positive and negative symptoms and functional recovery. Multivariate logistic regression and path analysis were employed to test the hypothesized relationships between symptom remission and FFR.
RESULTS: Remission of both positive and negative symptoms at 8-month follow-up predicted functional recovery at 14-month follow-up, but had limited value for the prediction of FFR at 7.5 years. Functional recovery at 14-month follow-up significantly predicted both FFR and remission of negative symptoms at 7.5 years, irrespective of whether remission criteria were simultaneously met. The association remained significant after controlling for baseline prognostic indicators.
CONCLUSIONS: These findings provided support for the hypothesis that early functional and vocational recovery plays a pivotal role in preventing the development of chronic negative symptoms and disability. This underlines the need for interventions that specifically address early psychosocial recovery.

Entities:  

Mesh:

Year:  2011        PMID: 21854682     DOI: 10.1017/S0033291711001504

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  34 in total

1.  Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Authors:  Barnaby Nelson; G Paul Amminger; Hok Pan Yuen; Nicky Wallis; Melissa J Kerr; Lisa Dixon; Cameron Carter; Rachel Loewy; Tara A Niendam; Martha Shumway; Sarah Morris; Julie Blasioli; Patrick D McGorry
Journal:  Early Interv Psychiatry       Date:  2017-07-18       Impact factor: 2.732

2.  The relationship of attitudinal beliefs to negative symptoms, neurocognition, and daily functioning in recent-onset schizophrenia.

Authors:  Joseph Ventura; Kenneth L Subotnik; Arielle Ered; Denise Gretchen-Doorly; Gerhard S Hellemann; Anja Vaskinn; Keith H Nuechterlein
Journal:  Schizophr Bull       Date:  2014-02-21       Impact factor: 9.306

3.  Predictors and Prevalence of Recovery and Remission for Consumers Discharged from Mental Hospitals in a Chinese Society.

Authors:  Daniel K W Young; Petrus Y N Ng; Jiayan Pan
Journal:  Psychiatr Q       Date:  2017-12

4.  Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.

Authors:  Chuan Shi; Xin Yu; Eric F C Cheung; David H K Shum; Raymond C K Chan
Journal:  Psychiatry Res       Date:  2013-12-21       Impact factor: 3.222

Review 5.  [Long-term treatment of schizophrenia spectrum disorders: focus on pharmacotherapy].

Authors:  L Deutschenbaur; M Lambert; M Walter; D Naber; C G Huber
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

6.  Characteristics associated with the pursuit of work and school among participants in a treatment program for first episode of psychosis.

Authors:  Jennifer L Humensky; Susan M Essock; Lisa B Dixon
Journal:  Psychiatr Rehabil J       Date:  2017-03

7.  Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms.

Authors:  Jimmy Lee; Hiroyoshi Takeuchi; Gagan Fervaha; Gwen Li Sin; George Foussias; Ofer Agid; Saeed Farooq; Gary Remington
Journal:  Can J Psychiatry       Date:  2015-11       Impact factor: 4.356

8.  Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial).

Authors:  Stefanie J Schmidt; Matthias Lange; Daniel Schöttle; Anne Karow; Benno G Schimmelmann; Martin Lambert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-05-24       Impact factor: 5.270

9.  Impact of interpersonal trauma on the social functioning of adults with first-episode psychosis.

Authors:  Helen J Stain; Kolbjørn Brønnick; Wenche T V Hegelstad; Inge Joa; Jan O Johannessen; Johannes Langeveld; Lauren Mawn; Tor K Larsen
Journal:  Schizophr Bull       Date:  2013-11-26       Impact factor: 9.306

10.  The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

Authors:  Ann M Kring; Raquel E Gur; Jack J Blanchard; William P Horan; Steven P Reise
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.